* Please note that program details may be subject to change.
* Simultaneous interpretation is available at this conference.
8:30 - |
Doors open開場
|
9:00 - 9:08 |
Opening Remarks開会挨拶
Mr. Yoshihiro HIRATA
Senior Managing Director
Media Business Nikkei Inc.
Mr.Katsunori WATANABE
Deputy mayor City of Yokohama
|
9:08 - 9:20 |
Special Messageスペシャルメッセージ
H.E. Mr. Félix Antoine TSHISEKEDI TSHILOMBO
President of the Democratic Republic of Congo
|
9:20 - 9:35 |
Keynote Speech 1基調講演1 野口英世アフリカ賞受賞
Dr. Jean-Jacques MUYEMBE-TAMFUM
General Director of National Institute for Biomedical Research(INRB), Professor of Microbiology, Faculty of Medicine, University of Kinshasa
|
9:35 - 9:50 |
Keynote Speech 2基調講演2 野口英世アフリカ賞受賞
Dr. Francis Gervase OMASWA
Executive Director and founder, African Centre for Global Health and Social Transformation (ACHEST)
|
9:50 - 10:00 |
Talk sessionトークセッション
Moderator
Dr. Takao TODA Ph.D.
Vice President for Human Security and Global Health Japan International Cooperation Agency
Dr. Jean-Jacques MUYEMBE-TAMFUM
General Director of National Institute for Biomedical Research(INRB), Professor of Microbiology, Faculty of Medicine, University of Kinshasa
Dr. Francis Gervase OMASWA
Executive Director and founder, African Centre for Global Health and Social Transformation (ACHEST)
|
10:05 - 10:15 |
Agenda1 - Defining the 6th Conference議題1 第6回会議の意義付け
Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus,
World Health Organization (WHO), Regional Office for Western Pacific
|
10:15 - 11:10 |
Agenda2 - Progress and Perspective of TB Consortium P3 Projects議題2 結核コンソーシアムのP3プロジェクトの進捗と今後の展望
Moderator
Dr. Kazunari ASANUMA, MD, PhD
Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare
-
Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization (WHO), Regional Office for Western Pacific
-
Kei KATSUNO, MD, MPH
Senior Director, Investment Strategy & Government Relations Global Health Innovative Technology Fund (GHIT Fund)
-
Dr. Seiya KATO
Director, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/ JATA)
-
Prof. Osamu KUNII, MD, MPH, PhD,
Head, Strategy, Investment and Impact Division The Global Fund to Fight AIDS, Tuberculosis and Malaria
-
Dr. Junko SATO, PhD
Office Director, Office of International Program Pharmaceuticals and Medical Devices Agency
-
Dr. Satoshi SHIMADA, MD, MTM, PhD
Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer Ministry of Health, Labour and Welfare
-
Prof. Nikki SHINDO, MD, PhD
Senior Advisor, WHO’s Health Emergency Programme (WHE), World Health Organization
-
Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
-
Mr. Ikuo TAKIZAWA
Deputy Director General, Human Development Department, Japan International Cooperation Agency
-
Dr. Hiroyuki NODA, MD, PhD
Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease / Councilor Cabinet Secretariat
-
Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
-
Dr. Yasuhiro YASUTOMI, DVM, PhD
Director, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine
-
Mr. Hiroshi YOSHIDA
Director, R&D, NIPRO CORPORATION
-
Mr. Hajime WATARI
Executive Officer, GM, Global Sales & Business Development EIKEN Chemical Co.,Ltd.
-
Dr. dr. Erlina BURHAN, Sp.P (K). MSc.
Head Division of Pulmonology Infection, Department of Pulmonology, Faculty of Medicine, Universitas Indonesia. Member of Infectious Disease and Immunology Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia
-
Dr. Abidan CHANSA
Consultant Physician/Member Clinical Expert Committee on TB Ministry of Health Zambia
-
Patricia A. DARRAH, Ph.D.
Head, Tuberculosis Unit Vaccine Research Center, NIAID, NIH
-
Dr. Lucica DITIU
Executive Director Stop TB Partnership
-
Mr. Celso Cachin MANANGAN
Member, International Board, Germany PPP Initiative Group (for the Establishment of the UNECE-affiliated PPP Centre of Excellence in Sustainable Health), Frankfurt am Main, Germany PPP Health Advisor, SDG.17 Consulting GmBH, Frankfurt am Main, Germany Head, Business Development, SteraMist Philippines
-
Dr. Amit N THAKKER
Chairman Africa Health Business
|
11:20 - 12:15 |
Agenda3 - Ebola Outbreaks in DRC; Emergency Usage of Unapproved Potential Medical Drugs議題3 エボラ出血熱流行~新興・再興感染症への未承認薬使用の必要性や課題を議論する
Moderator
Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
-
Dr. Kazunari ASANUMA, MD, PhD
Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare
-
Tatsuo IIYAMA, M.D.
Senior Manager, Executive Management Section, Department of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine (NCGM)
-
Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization (WHO), Regional Office for Western Pacific
-
Dr. Hiroyuki KATO, MD, DTM&H
President MEDECINS SANS FRONTIERES JAPAN
-
Dr. Satoshi SHIMADA, MD, MTM, PhD
Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer Ministry of Health, Labour and Welfare
-
Prof. Nikki SHINDO, MD, PhD
Senior Advisor, WHO’s Health Emergency Programme (WHE), World Health Organization
-
Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
-
Mr. Ikuo TAKIZAWA
Deputy Director General, Human Development Department, Japan International Cooperation Agency
-
Yasuhiro FUJIWARA, MD, PhD
Chief Executive Pharmaceuticals and Medical Devices Agency
-
Takeo HOJO (Mr.)
Managing Director Saraya Manufacturing (U) Ltd. Saraya Kenya Co., Ltd.
-
Mr. Akira YASUI
Councillor, Director General of Coordination Office of Measures on Emerging Infectious Diseases and Office for Pandemic Influenza Preparedness and Responses Cabinet Secretariat,
-
Prof. Jiro YASUDA PhD, DVM
Director, National Research Center for the Control and Prevention of Infectious Diseases (CCPID) & Professor, Institute of Tropical Medicine (NEKKEN), Nagasaki University
-
Mr. Koichi YAMADA
Pharmaceutical Division, Manager FUJIFILM Corporation
-
Dr. Seth BERKLEY
CEO Gavi, the Vaccine Alliance
-
Dr. Richard H. KASZYNSKI
Senior Medical Advisor Democratic Republic of Congo
-
Mr. Ryan MORHARD, JD
Lead, Global Health Security, World Economic Forum
-
Prof. Baron PETER PIOT MD PhD
Director and Handa Professor of Global Health London School of Hygiene & Tropical Medicine
-
Dr. Amit N THAKKER
Chairman Africa Health Business
|
12:30 - 13:30 |
Lunch Session - From Prevention to Treatment ---Issues in Asia and Japan's Contribution to their solutionランチセッション アジアにおける感染症の予防から治療まで~アジアの課題と日本の貢献~
Moderator
Dr. Kazuhiro TATEDA, MD, PhD
Department of Microbiology and Infectious Diseases,
Toho University School of Medicine
-
Yoshikazu ISHII, Ph.D.
Department of Microbiology and Infectious Diseases, Professor Toho University School of Medicine
-
Ichiro KURANE, M.D., Ph.D.
Honorary Staff Member, National Institute of Infectious Diseases
|
13:40 - 14:35 |
Agenda4 - Achievements of Malaria Consortium and its Future Challenges議題4 マラリアコンソーシアムの成果と課題
Moderator
Prof. Kiyoshi KITA
Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University
-
Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization (WHO), Regional Office for Western Pacific
-
Kei KATSUNO, MD, MPH
Senior Director, Investment Strategy & Government Relations Global Health Innovative Technology Fund (GHIT Fund)
-
Prof. Akira KANEKO, MD, PhD, DTM&H
Professor, Department of Parasitology, Osaka City University Graduate School of Medicine
-
Dr. Shigeyuki KANO, MD, PhD,Hon PhD (Mahidol)
Director, Department of Tropical Medicine and Malaria, Research Institute,National Center for Global Health and Medicine (NCGM)
-
Mr. Osamu SAKURAI (MPhil)
Risk Advisory, Public Sector/Manager Deloitte Touche Tohmatsu LLC
-
Dr. Satoshi SHIMADA, MD, MTM, PhD
Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer Ministry of Health, Labour and Welfare
-
Prof. Nikki SHINDO, MD, PhD
Senior Advisor, WHO’s Health Emergency Programme (WHE), World Health Organization
-
Prof. Dr. Tomohiko SUGISHITA
Department of International Affairs and Tropical Medicine Tokyo Women’s Medical University
-
Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
-
Mr. Ray NISHIMOTO
Executive Vice President Sumitomo Chemical Company, Ltd.
-
Dr. Hiroyuki NODA, MD, PhD
Office for Pandemic Influenza and New Infectious Diseases & Coordination Office of Measures on Emerging Infectious Disease / Councilor Cabinet Secretariat
-
Mr.Yutaka HADA
Public Affairs Department, Manager Toyota Tsusho Corporation
-
Mr. Yoshihide HIRUTA
Director of International Cooperation, International Business Management, Global Support Sysmex Corporation
-
Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
-
Dr. Yasuyoshi MORI, PhD
Biochemical Research Laboratory II / General Manager Eiken Chemical Co.,Ltd.
-
Dr. John NKENGASONG MSc, PHD
Director Africa Centers for Disease Control and Prevention (CDC)- African Union Commission
-
Assoc. Prof. Pratap SINGHASIVANON, MBBS, DTM & H, MPH, DrPH
Dean, Faculty of Tropical Medicine Mahidol University
-
Dr. Amit N THAKKER
Chairman Africa Health Business
|
14:45 - 15:40 |
Agenda5 - Global PPP against the Risks of AMR; Challenges towards the Next Step議題5 拡大する薬剤耐性(AMR)のリスクに対するグローバルな産官学連携の課題と次のステップ
Moderator
Mr. Yasuhide YAMADA
Former Director-General of Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat,Government of Japan
Executive Officer, SHIMIZU CORPORATION
-
Dr. Kazunari ASANUMA, MD, PhD
Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare
-
Hajime INOUE, MD, MPH, DrPH
Director General, Bureau of Strategic Planning National Center for Global Health and Medicine(NCGM)
-
Prof. Kazumasa OGURO
Professor Hosei University
-
Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization (WHO), Regional Office for Western Pacific
-
Dr. Junko SATO, PhD
Office Director, Office of International Program Pharmaceuticals and Medical Devices Agency
-
Ms. Takuko SAWADA
Director of the Board, Executive Vice President Shionogi & Co., Ltd.
-
Dr. Satoshi SHIMADA, MD, MTM, PhD
Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer Ministry of Health, Labour and Welfare
-
Dr. Kensuke SHOJI , MD, PhD
Division Chief National Center for Child Health and Development
-
Prof. Nikki SHINDO, MD, PhD
Senior Advisor, WHO’s Health Emergency Programme (WHE), World Health Organization
-
Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
-
Dr. Kazuhiro TATEDA, MD, PhD
Department of Microbiology and Infectious Diseases, Toho University School of Medicine
-
Yasunori TAWARAGI, PhD
Director, International Affairs Japan Pharmaceutical Manufacturers Association
-
Mr. Ryoji NORITAKE
CEO and Board Member, Health and Global Policy Institute (HGPI)
-
Director. Dr. Hideaki HANAKI, Ph, PhD
Director, Infection Control Research Center, Kitasato University
-
Dr. Kazuki HOSHINO, PhD
Technology Department, Vice President Daiichi Sankyo Biotech Co., Ltd.
-
Prof. Satoshi MITARAI MD, Ph.D.
Head, Dept. of Mycobacterium Reference and Research Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association
-
Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
-
Takeo MOROOKA, MD, MPH
Executive Officer, Head of Health Policy and Corporate Support MSD K.K.
-
Mr. Thomas B. CUENI
Director General International Federation of Pharmaceutical Manufacturers & Associations
-
Mr. Ryan MORHARD, JD
Lead, Global Health Security, World Economic Forum
-
Dr. Jean-Pierre PACCAUD, PhD
Director of Business Development and Corporate Strategy Global Antibiotic R&D Partnership Foundation (GARDP)
|
16:00 - 16:50 |
Breakout Session A-1分科会 A-1 |
Breakout Session B-1分科会 B-1 |
A-1
MSD/SHIONOGI
Efforts to realize the sustainable development and access of novel treatments for AMR持続可能な新規AMR治療薬等の開発とアクセスを実現する取り組み
Moderator
Toshinobu SATO, MD, PhD
Professor of President’s Office
Kurume University
-
Visiting Professor Osamu UTSUNOMIYA , MD, MPH, PhD
School of Medicine, Visiting Professor Keio University
-
Prof. Kazumasa OGURO
Professor Hosei University
-
Dr. Satoshi SHIMADA, MD, MTM, PhD
Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer Ministry of Health, Labour and Welfare
-
Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
-
Dr. Kazuhiro TATEDA, MD, PhD
Department of Microbiology and Infectious Diseases, Toho University School of Medicine
-
Yasunori TAWARAGI, PhD
Director, International Affairs Japan Pharmaceutical Manufacturers Association
-
Shoji MIYAGAWA, DVM.MS
Director, Division of Infectious Disease Research the Japan Agency for Medical Research and Development
-
Dr. Yoshinori YAMANO, Ph.D.
Chief Scientific Officer for Infectious Diseases, Pharmaceutical Research Division, SHIONOGI & CO., LTD.
-
Dr. Jean-Pierre PACCAUD, PhD
Director of Business Development and Corporate Strategy Global Antibiotic R&D Partnership Foundation (GARDP)
-
Mr. Paul SCHAPER, MPH, MA, MBA
Executive Director, Global Public Policy MSD
|
B-1
FUJIFILM Toyama Chemical
Current landscape and future prospects of antiviral treatment for SFTS (severe fever with thrombocytopenia syndrome) SFTS抗ウイルス剤治療の現状と課題
Moderator
Prof. Nikki SHINDO, MD, PhD
Senior Advisor, WHO’s Health Emergency Programme (WHE), World Health Organization
-
Dr. Kazunari ASANUMA, MD, PhD
Councillor for Environmental Health and Food Safety, Minister's Secretariat, Ministry of Health, Labour and Welfare
-
Masayuki SAIJO , MD, PhD
Director, Department of Virology 1, National Institute of Infectious Diseases
-
Dr. Junko SATO, PhD
Office Director, Office of International Program Pharmaceuticals and Medical Devices Agency
-
Prof. Dr. Masaki YASUKAWA, MD, PhD
Professor, Proteo-Science Center Ehime University
-
Mr. Koichi YAMADA
Pharmaceutical Division, Manager FUJIFILM Corporation
|
Breakout Session C-1分科会 C-1 |
Breakout Session D-1分科会 D-1 |
C-1
Sumitomo Chemical
Japan's Initiatives for Malaria Elimination in Africaアフリカにおけるマラリアeliminationに向けた日本の取り組み
Moderator
Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
-
Prof. Akira KANEKO, MD, PhD, DTM&H
Professor, Department of Parasitology, Osaka City University Graduate School of Medicine
-
Mr. Ray NISHIMOTO
Executive Vice President Sumitomo Chemical Company, Ltd.
-
Mr. Tatsuo MIZUNO
Board Member Malaria No More Japan
-
Prof. Noboru MINAKAWA Ph.D.
Professor, Institute of Tropical Medicine, Nagasaki University
|
D-1
Saraya
Jigger Infestation in Africa Sub Sahara Regions; Current Situation and Challengesアフリカにおけるスナノミ被害の現状と対策
Moderator
Mr. Michikazu KOSHIBA
Head, Center on Global Health Architecture/ General Manager, Social Impact Partnership Business Dept. MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.
-
Mr. Kozo AKINO
Member of the House of Councilors
-
Prof. Satoshi KANEKO, MD,MPH, PhD
Professor Institute of Tropical Medicine, Nagasaki University
-
Ms. Noriko SHIRASU
Executive Director RESULTS Japan
-
Takeo HOJO (Mr.)
Managing Director Saraya Manufacturing (U) Ltd. Saraya Kenya Co., Ltd.
|
17:00 - 17:50 |
Breakout Session A-2分科会 A-2 |
Breakout Session B-2分科会 B-2 |
A-2
MSD/SHIONOGI
Efforts to realize the sustainable development and access of novel treatments for AMR持続可能な新規AMR治療薬等の開発とアクセスを実現する取り組み
Moderator
Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
-
Prof. Kazumasa OGURO
Professor Hosei University
-
Toshinobu SATO, MD, PhD
Professor of President’s Office Kurume University
-
Dr. Satoshi SHIMADA, MD, MTM, PhD
Health Service Bureau, Infectious Diseases Control Division/ Global Infectious Diseases Research Officer Ministry of Health, Labour and Welfare
-
Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
-
Dr. Kazuhiro TATEDA, MD, PhD
Department of Microbiology and Infectious Diseases, Toho University School of Medicine
-
Yasunori TAWARAGI, PhD
Director, International Affairs Japan Pharmaceutical Manufacturers Association
-
Shoji MIYAGAWA, DVM.MS
Director, Division of Infectious Disease Research the Japan Agency for Medical Research and Development
-
Dr. Yoshinori YAMANO, Ph.D.
Chief Scientific Officer for Infectious Diseases, Pharmaceutical Research Division, SHIONOGI & CO., LTD.
-
Dr. Jean-Pierre PACCAUD, PhD
Director of Business Development and Corporate Strategy Global Antibiotic R&D Partnership Foundation (GARDP)
-
Mr. Paul SCHAPER, MPH, MA, MBA
Executive Director, Global Public Policy MSD
|
B-2
DAIICHI SANKYO
Vaccine hesitancy: A global threat to fighting against infectious diseases, which can be prevented by vaccines「予防接種への躊躇」~ ワクチンで予防可能な感染症の制御を脅かすグローバル課題 ~
Moderator
Dr. Norihito UEDA, MD, PhD
Senior Medical Director, Biologics Planning Department, Biologics Division DAIICHI SANKYO CO., LTD.
-
Dr. Nobuhiko OKABE, MD, Ph.D.
Director General, Kawasaki City Institute for Public Health
-
Prof. Nikki SHINDO, MD, PhD
Senior Advisor, WHO’s Health Emergency Programme (WHE), World Health Organization
-
Shuichiro HAYASHI, MD, MPH
Director,Immunization Office, Health Service Division, Health Service Bureau Ministry of Health, Labour and Welfare
-
Mr. Hisahiko YANO
Senior Staff Writer Editional Bureau Nikkei Inc.
-
Mr. Thomas B. CUENI
Director General International Federation of Pharmaceutical Manufacturers & Associations
-
Dr. Gary DUBIN, MD
Senior Vice President and Head, Global Medical Office, Vaccine Business Unit Takeda Pharmaceuticals Company Limited
-
Dr. Jean-Jacques MUYEMBE-TAMFUM
General Director of National Institute for Biomedical Research(INRB), Professor of Microbiology, Faculty of Medicine, University of Kinshasa
|
Breakout Session C-2分科会 C-2 |
Breakout Session D-2分科会 D-2 |
C-2
SYSMEX
Malaria-free Continent: Africa and Japan working together for sustainable growthマラリアのない大陸へ:持続的な成長に向けた日本・アフリカの協働
Moderator
Prof. Dr. Tomohiko SUGISHITA
Department of International Affairs and Tropical Medicine
Tokyo Women’s Medical University
-
Prof. Theresa L COETZER, PhD
Research Professor Wits Research Institute for Malaria Department of Molecular Medicine and Haematology University of the Witwatersrand
-
Ms. Samantha GIANGREGORIO
Managing Director, Essential Health Care, Sysmex EMEA (Europe, Middle East and Africa)
-
Dr. Francis Gervase OMASWA
Executive Director and founder, African Centre for Global Health and Social Transformation (ACHEST)
-
Mr. Eric OSEI
MANAGING DIRECTOR Sysmex West and Central Africa Ltd
-
Dr. Amit N THAKKER
Chairman Africa Health Business
|
D-2
FUMAKILLA
Development of Mosquito Killer Products in Asia and Its Application to Malaria Control in Africaアジアにおける蚊殺虫剤製品の展開と、アフリカのマラリア対策への応用について
Moderator
Prof. Noboru MINAKAWA Ph.D.
Professor, Institute of Tropical Medicine, Nagasaki University
-
Hajime INOUE, MD, MPH, DrPH
Director General, Bureau of Strategic Planning National Center for Global Health and Medicine(NCGM)
-
Dr. Hitoshi KAWADA
Institute of Tropical Medicine / Associate Professor Nagasaki University
-
Mr. Tatsuo MIZUNO
Board Member Malaria No More Japan
-
Mr. Toshiaki MURAMOTO
Director, International planning department manager and in charge of Fumakilla Vietnam operation Fumakilla Limited
|